Walbert Keli
Reporting owner on Forms 3, 4 and 5, CIK 2051489.
Walbert Keli reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-09-25.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Hemab Therapeutics Holdings, Inc. CIK 2114044 | director | 1 | 2026-09-25 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Hemab Therapeutics Holdings… Stock Option (Right to Buy), derivative | 2026-09-24 | A granted | +36,000 | $0 | 36,000 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001193125-26-402936 | Hemab Therapeutics Holdings, Inc. | 2026-09-25 | ||
| Form 3 0001193125-26-402904 | Hemab Therapeutics Holdings, Inc. | 2026-09-25 |